Kingway Financial News | Wuxi Bio (02269) is strong and volatile, up 8.14% as of press time, trading at HK$17.28, with a turnover of 2.102 billion Hong Kong dollars.
On the news front, on September 23rd local time in the USA, Gary Peters, Chairman of the Senate Committee on Homeland Security and Governmental Affairs, submitted an amendment, S.3558, to the U.S. Senate. Previously known as the Senate version of the "Biodefense Bill," the S.3558 bill was approved with a vote of 11 in favor and 1 against at a hearing held by the Senate Committee on Homeland Security and Governmental Affairs in March of this year.
In this amendment, the S.3558 bill was officially renamed the "2024 Foreign Restrictions on U.S. Genetic Information Act." The Senate Committee on Homeland Security and Governmental Affairs made some revisions to the early versions of the bill, with no changes to the list of entities involved. Wuxi Bio does not appear on the list, while Wuxi AppTec (02359) and BGI Group are still listed.